Universal Health Services, Inc. logo

Universal Health Services, Inc.

UHS

NYSEHealthcareMedical - Care Facilities

Previous close

$177.26

+$4.39 · +2.54%

Aug 21, 4:00 PM ET

Pre-market

$177.5

+$0.24 · +0.14%

Aug 24, 5:58 AM ET

UHS company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

98

Deep Value

Momentum

31

Weakening

Sentiment

78

Bullish

Risk resilience

58

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Marc D. Miller
Listed since
Jul 9, 1981
Employees
102,000

Market position

Day range

Current $177.26

52-week range

Current $177.26

Open
$173.8
Previous close
$172.87
Volume
446.99K
0.45× average
Average volume
983.63K
Average daily volume
Market cap
10.73B USD
Beta
1.06
Market reference 1
50-day average
$157.76
+12.36% above average
200-day average
$188.73
-6.08% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
19.23B USD
P/E (TTM)
7.19×
P/B (TTM)
1.41×
P/S (TTM)
0.59×
EV / EBITDA
7.01×
Earnings yield
10.74%
Free cash flow yield
6.13%
Dividend yield
0.45%

Profitability & efficiency

Gross margin
90.69%
Operating margin
11.36%
Net margin
8.42%
Return on equity
20.46%
Return on assets
9.33%
Return on invested capital
11.29%

Financial health

Debt / equity
0.7×
Current ratio
1.05×
Altman Z-score
3.12
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends99%65%31%-4%Gross margin, FY2021: 88.71%Gross margin, FY2022: 89.00%Gross margin, FY2023: 89.27%Gross margin, FY2024: 89.97%Gross margin, FY2025: 90.45%Operating margin, FY2021: 10.78%Operating margin, FY2022: 7.49%Operating margin, FY2023: 8.23%Operating margin, FY2024: 10.63%Operating margin, FY2025: 11.48%Net margin, FY2021: 7.84%Net margin, FY2022: 5.04%Net margin, FY2023: 5.03%Net margin, FY2024: 7.22%Net margin, FY2025: 8.57%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 88.71%. Gross margin FY2022 89.00%. Gross margin FY2023 89.27%. Gross margin FY2024 89.97%. Gross margin FY2025 90.45%. Operating margin FY2021 10.78%. Operating margin FY2022 7.49%. Operating margin FY2023 8.23%. Operating margin FY2024 10.63%. Operating margin FY2025 11.48%. Net margin FY2021 7.84%. Net margin FY2022 5.04%. Net margin FY2023 5.03%. Net margin FY2024 7.22%. Net margin FY2025 8.57%.

Income trends

Revenue

17.36B USD+9.71%

Operating income

1.99B USD+18.56%

Net income

1.49B USD+30.36%
Income trends across reported periods19.03B USD12.36B USD5.68B USD−993.31M USDRevenue, FY2021: 12.64B USDRevenue, FY2022: 13.4B USDRevenue, FY2023: 14.28B USDRevenue, FY2024: 15.83B USDRevenue, FY2025: 17.36B USDOperating income, FY2021: 1.36B USDOperating income, FY2022: 1B USDOperating income, FY2023: 1.18B USDOperating income, FY2024: 1.68B USDOperating income, FY2025: 1.99B USDNet income, FY2021: 991.59M USDNet income, FY2022: 675.61M USDNet income, FY2023: 717.8M USDNet income, FY2024: 1.14B USDNet income, FY2025: 1.49B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 12.64B USD. Revenue FY2022 13.4B USD. Revenue FY2023 14.28B USD. Revenue FY2024 15.83B USD. Revenue FY2025 17.36B USD. Operating income FY2021 1.36B USD. Operating income FY2022 1B USD. Operating income FY2023 1.18B USD. Operating income FY2024 1.68B USD. Operating income FY2025 1.99B USD. Net income FY2021 991.59M USD. Net income FY2022 675.61M USD. Net income FY2023 717.8M USD. Net income FY2024 1.14B USD. Net income FY2025 1.49B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue17.36B USD15.83B USD14.28B USD13.4B USD12.64B USD
Cost of goods sold1.66B USD1.59B USD1.53B USD1.47B USD1.43B USD
Gross profit15.71B USD14.24B USD12.75B USD11.93B USD11.21B USD
Selling, general, and administrative8.23B USD7.67B USD7.25B USD6.89B USD6.28B USD
Operating expenses13.71B USD12.56B USD11.57B USD10.92B USD9.85B USD
Interest income1.19M USD1.43M USD572K USD378K USD1.6M USD
Interest expense157.26M USD187.53M USD207.25M USD127.27M USD85.27M USD
Depreciation and amortization618.74M USD584.83M USD568.04M USD581.86M USD533.21M USD
Operating income1.99B USD1.68B USD1.18B USD1B USD1.36B USD
Net income1.49B USD1.14B USD717.8M USD675.61M USD991.59M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
91%
10 beats, 1 miss, 0 met estimates
Average EPS surprise
+11.09%
11 comparable reports
Latest EPS result
5.98
Estimate 5.94 · Beat by 0.67%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates6.225.474.723.97Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 26, 2025: actual 4.92, estimate 4.21, surprise +16.86%, Beat. Q2 2025, reported Apr 28, 2025: actual 4.84, estimate 4.35, surprise +11.26%, Beat. Q3 2025, reported Jul 28, 2025: actual 5.35, estimate 4.92, surprise +8.74%, Beat. Q4 2025, reported Oct 27, 2025: actual 5.69, estimate 4.66, surprise +22.10%, Beat. Q1 2026, reported Feb 25, 2026: actual 5.88, estimate 5.92, surprise -0.68%, Miss. Q2 2026, reported Apr 27, 2026: actual 5.62, estimate 5.41, surprise +3.88%, Beat. Q3 2026, reported Jul 27, 2026: actual 5.98, estimate 5.94, surprise +0.67%, Beat. Q4 2026, reported Oct 26, 2026: actual —, estimate 5.28, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates4.91B4.55B4.18B3.82BQ1 '25BeatQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 26, 2025: actual 4.11B USD, estimate 4.01B USD, surprise +2.69%, Beat. Q2 2025, reported Apr 28, 2025: actual 4.1B USD, estimate 4.15B USD, surprise -1.32%, Miss. Q3 2025, reported Jul 28, 2025: actual 4.28B USD, estimate 4.24B USD, surprise +1.09%, Beat. Q4 2025, reported Oct 27, 2025: actual 4.5B USD, estimate 4.5B USD, surprise -0.21%, Miss. Q1 2026, reported Feb 25, 2026: actual 4.49B USD, estimate 4.5B USD, surprise -0.41%, Miss. Q2 2026, reported Apr 27, 2026: actual 4.5B USD, estimate 4.39B USD, surprise +2.45%, Beat. Q3 2026, reported Jul 27, 2026: actual 4.64B USD, estimate 4.58B USD, surprise +1.29%, Beat. Q4 2026, reported Oct 26, 2026: actual —, estimate 4.72B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$193

8.88% upside
Past 12 months12-month forecastHigh $290Average $193Low $166

Rating distribution

43 ratings
Strong buy00%
Buy1637%
Hold2558%
Sell25%
Strong sell00%

UHS peers

ETFs holding UHS

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research UHS

research.disclaimer